IFPMA

ifpma | February 09, 2017

Entering the campaign’s fourth year, Fight the Fakes (www.fightthefakes.org) is pleased to announce the rotation of its secretariat to the International Federation of Pharmaceutical Wholesalers (IFPW), and made possible through the support of IFPW Foundation....

ifpma | February 16, 2017

IFPMA, the international association representing the innovative biopharmaceutical industry, welcomes the G-FINDER 2016[1] results, which shows that industry consolidated its status as a main funder of neglected disease R&D in 2015....

ifpma | February 28, 2017

Celebrating Rare Disease Day 2017, IFPMA launches today new resources to help increase understanding and awareness of rare diseases. These include a set of policy principles outlining critical elements for a global framework on rare disease policy and a report that describes key challenges in areas such as R&D, clinical trials, diagnosis, and access to treatment....

ifpma | March 09, 2017

Switching describes a physician’s decision to exchange one product that a patient receives for another. With the introduction of biosimilars, physicians may be encouraged to switch patients from an original biologic (reference product) to any of its biosimilars (or vice versa) in order to reduce costs....